HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.

AbstractBACKGROUND:
MAP2K4 is a putative tumor and metastasis suppressor gene frequently found to be deleted in various cancer types. We aimed to conduct a comprehensive analysis of this gene to assess its involvement in ovarian cancer.
METHODS:
We screened for mutations in MAP2K4 using High Resolution Melt analysis of 149 primary ovarian tumors and methylation at the promoter using Methylation-Specific Single-Stranded Conformation Polymorphism analysis of 39 tumors. We also considered the clinical impact of changes in MAP2K4 using publicly available expression and copy number array data. Finally, we used siRNA to measure the effect of reducing MAP2K4 expression in cell lines.
RESULTS:
In addition to 4 previously detected homozygous deletions, we identified a homozygous 16 bp truncating deletion and a heterozygous 4 bp deletion, each in one ovarian tumor. No promoter methylation was detected. The frequency of MAP2K4 homozygous inactivation was 5.6% overall, and 9.8% in high-grade serous cases. Hemizygous deletion of MAP2K4 was observed in 38% of samples. There were significant correlations of copy number and expression in three microarray data sets. There was a significant correlation between MAP2K4 expression and overall survival in one expression array data set, but this was not confirmed in an independent set. Treatment of JAM and HOSE6.3 cell lines with MAP2K4 siRNA showed some reduction in proliferation.
CONCLUSIONS:
MAP2K4 is targeted by genetic inactivation in ovarian cancer and restricted to high grade serous and endometrioid carcinomas in our cohort.
AuthorsSally J Davis, David Y H Choong, Manasa Ramakrishna, Georgina L Ryland, Ian G Campbell, Kylie L Gorringe
JournalBMC cancer (BMC Cancer) Vol. 11 Pg. 173 ( 2011) ISSN: 1471-2407 [Electronic] England
PMID21575258 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tumor Suppressor Proteins
  • MAP Kinase Kinase 4
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Base Sequence
  • Cell Proliferation
  • DNA Methylation (genetics)
  • Female
  • Gene Dosage (genetics)
  • Gene Expression Regulation, Neoplastic (genetics)
  • Gene Knockdown Techniques
  • Genotype
  • Humans
  • MAP Kinase Kinase 4 (genetics)
  • Middle Aged
  • Molecular Sequence Data
  • Mutation (genetics)
  • Ovarian Neoplasms (enzymology, genetics, mortality)
  • Promoter Regions, Genetic (genetics)
  • Survival Analysis
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: